Codexis, Inc. (CDXS) vs Outlook Therapeutics, Inc. (OTLK)
Codexis, Inc. and Outlook Therapeutics, Inc. are both Biotechnology companies. Codexis, Inc. and Outlook Therapeutics, Inc. are of similar size ($159.5M and $150.0M). Codexis, Inc. grew revenue faster over the last twelve months: 35.9% against −113.6%. Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs −39.6%) and the higher return on invested capital (0.00% vs −151.2%). Across the 16 metrics below, Outlook Therapeutics, Inc. leads on 10 and Codexis, Inc. on 6.
Valuation
Profitability
| Metric | CDXS | OTLK | Biotechnology median |
|---|---|---|---|
| Gross margin | 87.02% | 195.62% | 65.16% |
| Operating margin | (35.61%) | 4,781.76% | 0.00% |
| Net margin | (39.55%) | 5,253.40% | 0.00% |
| Free cash flow margin | (15.66%) | 4,826.38% | 0.00% |
| Return on equity | (69.36%) | 256.92% | (57.72%) |
| Return on assets | (23.79%) | (251.66%) | (49.22%) |
| Return on invested capital | (151.17%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack